Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
L. Laine, W.L. Peterson.
Bleeding peptic ulcer.
N Engl J Med, 331 (1994), pp. 717-727
[2.]
F.J. Branicki, S.Y. Coleman, P.J. Fok, C.J. Pritchett, S.T. Fan, E.C. Lai, et al.
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality.
World J Surg, 14 (1990), pp. 262-269
[3.]
E.M. Vreeburg, C.B. Terwee, P. Snel, E.A.J. Rauws, JFWM Bartelsman, J.H.P. Meulen, et al.
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding.
Gut, 44 (1999), pp. 331-335
[4.]
J. Llach, J.M. Bordas, J.M. Salmerón, J. Panés, J.C. García Pagán, F. Feu, et al.
A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhage.
Gastrointest Endosc, 43 (1996), pp. 117-120
[5.]
P.C. Bornman, N.A. Theodorou, R.D. Suttleworth, H.P. Essel, I.N. Marks.
Importance of hypovoloamic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation.
BMJ, 291 (1985), pp. 245-247
[6.]
D.R. Bordley, A.I. Mushlin, J.G. Dolan, W.S. Richardson, M. Barry, J. Polio, et al.
Early clinical signs identify low-risk patients with acute upper gastrointestinal hemorrhage.
JAMA, 253 (1985), pp. 3282-3285
[7.]
F.T. De Dombal, J.R. Clarke, S.E. Clamp, G. Malicia, M.R. Kotwal, A.G. Morgan.
Prognostic factors in upper GI bleeding.
Endoscopy, 18 (1986), pp. 6-10
[8.]
T.A. Rockall, R.F.A. Logan, H.B. Devlin, T.C. Northfield.
Risk assessment after acute upper gastrointestinal haemorrhage.
Gut, 38 (1996), pp. 316-321
[9.]
T.A. Rockall, R.F.A. Logan, H.B. Devlin, T.C. Northfield.
for the National Audit of Acute Upper Gastrointestinal Haemorrhage. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage.
Lancet, 347 (1996), pp. 1138-1140
[10.]
D.J. Cook, G.H. Guyatt, B.J. Salena, L.A. Laine.
Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.
Gastroenterology, 102 (1992), pp. 139-148
[11.]
A. Pardo, R. Durández, M. Hernández, A. Pizarro, M. Hombrados, A. Jiménez, et al.
Impact of physician specialty on the cost of nonvariceal upper GI bleeding care.
Am J Gastroenterol, 97 (2002), pp. 1535-1542
[12.]
W.H. Bickell, M.J. Wall, P.E. Pepe, R.R. Martin, V.F. Ginger, M.K. Allen, et al.
Immediate versus delayed resuscitation for hypotensive patients with penetrating torso injuries.
N Engl J Med, 331 (1994), pp. 1105-1109
[13.]
P.C. Herbert, G. Wells, M.A. Blajchman, J. Marshall, C. Martin, G. Pagliarello, et al.
A multicenter, randomizedcontrolled clinical trial on transfusion requirements in critical care.
N Engl J Med, 340 (1999), pp. 409-417
[14.]
W.H. Bickell, S.P. Bruttig, G.A. Millnamow, J. O'Benar, C.E. Wade.
The detrimental effects of intravenous crystalloid after aortotomy in swine.
Surgery, 110 (1991), pp. 529-536
[15.]
S.A. Stern, S.C. Dronen, P. Birrer, X. Wang.
Effect of blood pressure on haemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury.
Ann Emerg Med, 22 (1993), pp. 155-163
[16.]
J.M. Duggan.
Haematemesis patients should be managed in special units.
Med J Aust, 44 (1986), pp. 247-250
[17.]
S.B. Rofe, J.M. Duggan, E.R. Smith, C.J. Thrusby.
Conservative treatment of gastrointestinal haemorrhage.
Gut, 26 (1981), pp. 481-484
[18.]
S.D. Blair, S.B. Janvrin, C.N. McCollum, R.M. Greenhalgh.
Effect of early blood transfusion on gastrointestinal haemorrhage.
Br J Surg, 73 (1986), pp. 783-785
[19.]
R.B. Dawson.
Preservation of red cells for transfusión.
Hum Pathol, 14 (1983), pp. 213-217
[20.]
J.G.A. Houbiers, A. Brand, L.M.G. Van de Watering, J. Hermans, P.J. Verwey, A.B. Bijnen, et al.
Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
Lancet, 344 (1994), pp. 573-577
[21.]
J.I. Elizalde, J. Clemente, J.L. Marin, J. Panes, B. Aragon, A. Mas, et al.
Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia.
Transfusion, 37 (1997), pp. 573-576
[22.]
L. Laine, H. Cohen, J. Bordead, D. Cantor, F. Garcia, M. Mosquera.
Prospective evaluation of immediate versus delayed re-feeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage.
Gastroenterology, 102 (1992), pp. 314-316
[23.]
V. De Ledinghen, P. Beau, P.R. Mannant, M.P. Ripault, C. Borderie, C. Silvain, et al.
When should patients with bleeding peptic ulcer resume oral intake?.
A randomized controlled study. Gastroenterol Clin Biol, 22 (1998), pp. 282-285
[24.]
A. Chak, G.S. Cooper, L.E. Lloyd, C.S. Kolz, B.A. Barnhart.
Wong RCK. Effectiveness of endoscopy in patients admitted to the intensive care unit with upper GI hemorrhage.
Gastrointest Endosc, 53 (2001), pp. 6-13
[25.]
P. Hsu, K. Lai, X. Lin, Y.F. Yang, M. Lin, J.S. Shin, et al.
When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of bleeding.
Gastrointest Endosc, 44 (1996), pp. 382-387
[26.]
R. Campo, E. Brullet, X. Calvet, et al.
Safety of outpatient management of nonvariceal upper gastrointestinal bleeding: preliminary results of a randomized study.
Gastrointest Endosc, 47 (1998), pp. AB81
[27.]
K. Lai, W. Hui, B. Wong, C. Cing, S. Lam.
A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy.
Gastrointest Endosc, 45 (1998), pp. 26-30
[28.]
G.F. Longstreth, S.P. Feitelberg.
Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series.
Gastrointest Endosc, 47 (1998), pp. 219-221
[29.]
J.G. Lee, S. Turnipseed, P.S. Romano, H. Vigil, R. Azari, N. Melnikoff, et al.
Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial.
Gastrointest Endosc, 50 (1999), pp. 755-761
[30.]
H.J. Lin, K. Wang, C.L. Perng, R.T. Chua, F.Y. Lee, C.H. Lee, et al.
Early or delayed endoscopy for patients with peptic ulcer bleeding: a prospective randomized study.
J Clin Gastroenterol, 22 (1996), pp. 267-271
[31.]
G.S. Cooper, A. Chak, A.F. Connors, D.L. Harper, G.E. Rosenthal.
The effectiveness of early endoscopy for upper gastrointestinal hemorrhage.
Med Care, 36 (1998), pp. 462-474
[32.]
G.S. Cooper, A. Chak, L. Way, P. Hammar, D. Harper, G. Rosenthal.
Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay.
Gastrointest Endosc, 49 (1999), pp. 145-152
[33.]
J.A. Hay, L. Maldonado, S.R. Weingarten, G.A. Ellrodt.
Prospective evaluation of a clinical guideline recommending hospital length of stay in upper gastrointestinal tract hemorrhage.
JAMA, 278 (1997), pp. 2152-2156
[34.]
J. Panés, J. Viver, M. Forné, E. García-Olivares, C. Marco, J. Garau.
Controlled trial of endoscopic sclerosis in bleeding peptic ulcers.
Lancet, 2 (1987), pp. 1292-1294
[35.]
D.M. Jensen, T.O.G. Kovacs, R. Jutabha, G.A. Machicado, I.M. Gralnek, T.J. Savides, et al.
Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots.
Gastroenterology, 123 (2002), pp. 407-413
[36.]
B.L. Bleau, C.J. Gostout, K.E. Sherman, M.J. Shaw, W.V. Harford, R.F. Keate, et al.
Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy.
Gastrointest Endosc, 56 (2002), pp. 1-6
[37.]
K.R. Palmer, C.P. Choudari.
Endoscopic intervention in bleeding peptic ulcer.
Gut, 37 (1995), pp. 161-164
[38.]
C. Villanueva, J. Balanzó, X. Torras, G. Soriano, S. Sainz, F. Vilardell.
Value of second-look endoscopy after injection therapy for bleeding peptic ulcer: a prospective and randomized trial.
Gastrointest Endosc, 40 (1994), pp. 34-39
[39.]
J.I. Elizalde, J. Llach, J.M. Bordas, R. Bataller, F. Mondelo, J. Panés, et al.
Valor del control endoscópico tras la escleroterapia por lesión péptica gastroduodenal.
Gastroenterol Hepatol, 17 (1994), pp. 11-13
[40.]
Z.A. Saeed, C.B. Winchester, P.A. Michaletz, K.L. Woods, D.Y. Graham.
A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal hemorrhage, with a comparison of heat probe and ethanol injection.
Am J Gastroenterol, 88 (1993), pp. 1842-1849
[41.]
J.A. Hay, E. Lyubashevsky, J. Elashoff, L. Maldonado, S.R. Weingarten, G.A. Ellrodt.
Upper gastrointestinal hemorrhage clinical guideline – Determining the optimal hospital length of stay.
Am J Med, 100 (1996), pp. 313-322
[42.]
C. Villanueva, J. Balanzó, J.C. Espinós, J.M. Domènech, S. Sáinz, J. Call, et al.
Prediction of therapeutic failure in patients with bleeding peptic ulcer treated with endoscopic injection.
Dig Dis Sci, 38 (1993), pp. 2062-2070
[43.]
Z.A. Saeed, F.C. Ramírez, K.S. Hepps, R.A. Cole, D.Y. Graham.
Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers.
Gastrointest Endosc, 41 (1995), pp. 561-565
[44.]
K.G. Park, R.J. Steele, J. Mollison, T.J. Crofts.
Prediction of recurrent bleeding after endoscopic haemostasis in non-variceal upper gastrointestinal haemorrhage.
Br J Surg, 81 (1994), pp. 1465-1468
[45.]
E. Brullet, X. Calvet, R. Campo, M. Rue, L. Catot, L. Donoso.
Factors oredicting failure of endoscopic injection therapy in bleeding duodenal ulcer.
Gastrointest Endosc, 43 (1996), pp. 111-116
[46.]
E. Brullet, R. Campo, X. Calvet, D. Coroleu, E. Rivero, J. Simo Deu.
Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer.
Gut, 39 (1996), pp. 155-158
[47.]
S.K. Wong, L.M. Yu, J.Y. Lau, Y.H. Lam, A.C. Chan, E.K. Ng, et al.
Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer.
Gut, 50 (2002), pp. 322-325
[48.]
P. Moreno, E. Jaurrieta, H. Aranda, J. Fabregat, L. Farran, S. Biondo, et al.
Efficacy and safety of an early discharge protocol in low-risk patients with upper gastrointestinal bleeding.
Am J Med, 105 (1998), pp. 176-181
[49.]
O. Blatchford, W.R. Murray, M. Blatchford.
A risk score to predict need for treatment for upper-gastrointestinal haemorrhage.
Lancet, 356 (2000), pp. 1318-1321
[50.]
T.S. Phang, V. Vornik, R. Stubbs.
Risk assessment in upper gastrointestinal haemorrhage: implications for resource utilisation.
N Z Med J, 113 (2000), pp. 33-333
[51.]
N.I. Church, K.R. Palmer.
Relevance of the Rockall score in patients undergoing endoscopic therapy for peptic ulcer haemorrhage.
Eur J Gastroenterol Hepatol, 13 (2001), pp. 1149-1152
[52.]
F. Feu, A. Mata, M. Peñalva, A. Blasco, J.M. Piqué.
Application of a clinical guideline for upper gastrointestinal bleeding using Rockall score shortens hospital stay without affecting mortality.
Gastroenterology, 122 (2002), pp. A477
[53.]
G.F. Longstreth, S.B. Feitelberg.
Successful outpatient management of acute upper gastrointestinal hemorrhage: use of practice guidelines in a large patient series.
Gastrointest Endosc, 47 (1998), pp. 219-222
[54.]
L. Cipolletta, M.A. Bianco, G. Rotondano, R. Marmo, R. Piscopo.
Outpatient management for low-risk nonvariceal upper GI bleeding: a randomized controlled trial.
Gastrointest Endosc, 55 (2002), pp. 1-5
[56.]
L. Laine.
Multipolar electrocoagulation in the treatment of peptic ulcers with nonbleeding visible vessels.
Ann Intern Med, 110 (1989), pp. 510-514
[57.]
H.J. Lin, F.Y. Lee, W.M. Kang, Y.T. Tsai, S.D. Lee, C.H. Lee.
A controlled study of therapeutic endoscopy for peptic ulcer with non-bleeding visible vessel.
Gastrointest Endosc, 36 (1990), pp. 241-246
[58.]
J.L. Jaramillo, C. Carmona, C. Gálvez, M. De la Mata, G. Miño.
Efficacy of the heater probe in peptic ulcer with a non-bleeding visible vessel. A controlled, randomised study.
Gut, 34 (1993), pp. 1502-1506
[59.]
P. Rutgeerts, A.M. Gevers, M. Hiele, L. Broeckaert, G. Vantrappen.
Endoscopic injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial.
Gut, 34 (1993), pp. 348-350
[60.]
A. Parra-Blanco, H. Takahashi, P.V. Méndez Jerez, T. Kojima, K. Aksoz, K. Kirihara, et al.
Endoscopic mangement of Dieulafoy lesions of the stomach: a case study of 26 patients.
Endoscopy, 29 (1997), pp. 834-839
[61.]
I.K. Chung, E.J. Kim, M.S. Lee, H.S. Kim, S.H. Park, M.H. Lee, et al.
Bleeding Dieulafoy's lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods.
Gastrointest Endosc, 52 (2000), pp. 721-724
[62.]
P. Kasapidis, P. Georgopoulos, V. Delis, V. Balatsos, A. Konstantinidis, N. Skandalis.
Endoscopic management and long-term follow-up of Dieulafoy's lesions in the upper GI tract.
Gastrointest Endosc, 55 (2002), pp. 527-531
[63.]
J. Llach, J.I. Elizalde, M.C. Guevara, M. Pellise, A. Castellot, A. Gines, et al.
Endoscopic injection therapy in bleeding Mallory-Weiss syndrome: a randomized controlled trial.
Gastrointest Endosc, 54 (2001), pp. 679-681
[64.]
P. Rutgeerts, E. Rauws, P. Wara, P. Swain, A. Hoos, E. Solleder, et al.
Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer.
Lancet, 350 (1997), pp. 692-696
[65.]
J. Balanzó, S. Sainz, J. Such, J.C. Espinós, C. Guarner, X. Cussó, J. Monés, F. Vilardell.
Endoscopic hemostasis by local injection of epinephrine and polidocanol in bleeding ulcer. A prospective randomized trial.
Endoscopy, 20 (1988), pp. 289-291
[66.]
S.C.S. Chung, J.W.C. Leung, R.J.C. Steele, T.J. Crofts.
Li AKC. Endoscopic injection of adrenaline for actively bleeding ulcers: a randomized trial.
BMJ, 296 (1988), pp. 1631-1633
[67.]
R.B.G. Oxner, N.J. Simmonds, D.J. Gertner, J.M.D. Nightingale, W.R. Burnham.
Controlled trial of endoscopic injection treatment for bleeding from peptic ulcers with visible vessels.
Lancet, 339 (1992), pp. 966-968
[68.]
H.J. Lin, C.L. Perng, S.D. Lee.
Is sclerosant injection mandatory after an epinephrine injection for arrest of peptic ulcer hemorrhage?.
A prospective, randomized, comparative study. Gut, 34 (1993), pp. 1182-1185
[69.]
A.K. Kubba, K.R. Palmer.
Role of endoscopic injection therapy in the treatment of bleeding ulcer.
Br J Surg, 83 (1996), pp. 461-468
[70.]
S.C. Chung, J.L. Lau, J.J. Sung.
Randomised comparison between adrenaline injection alone and adrenaline injection plus heater probe treatment for actively bleeding peptic ulcers.
BMJ, 314 (1997), pp. 1307-1317
[71.]
H.J. Lin, Y.H. Hsieh, G.Y. Tseng, C.L. Perng, F.Y. Chang, S.D. Lee.
A prospective, randomized trial of large-versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding.
Gastrointest Endosc, 55 (2002), pp. 615-619
[72.]
H.J. Lin, F.Y. Lee, W.M. Kang, Y.T. Tsai, S.D. Lee, C.H. Lee.
Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial.
Gut, 31 (1990), pp. 753-757
[73.]
I.K. Chung, J.S. Ham, H.S. Kim.
Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline-epinephrine injection and a combination of the two for the management of bleeding peptic ulcers.
Gastrointest Endosc, 49 (1999), pp. 13-18
[74.]
L. Cipolletta, M.A. Bianco, R. Marmo, G. Rotondano, R. Piscopo, A.M. Vingiani, et al.
Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: a prospective and randomized trial.
Gastrointest Endosc, 53 (2001), pp. 147-151
[75.]
D. Abi-Hanna, S.J. Williams, P.A. Gillespie, M.J. Bourke.
Endoscopic band ligation for nonvariceal non ulcer gastrointestinal hemorrhage.
Gastrointest Endosc, 48 (1998), pp. 510-514
[76.]
R.M. Wong, S. Ota, A. Katoh, A. Yamanchi, K. Arai, K. Yaneko, et al.
Endoscopic ligation for non-variceal esophageal upper gastrointestinal hemorrhage.
Endoscopy, 30 (1998), pp. 774-777
[77.]
P. Rutgeerts, G. Vantrappen, L. Broeckaert, G. Coremans, J. Janssens, M. Hiele.
Comparison of endoscopic polidocanol injection and YAG laser therapy for bleeding peptic ulcers.
Lancet, 1 (1989), pp. 1164-1167
[78.]
G.J. Krejs, K.H. Little, H. Westergaard, J.K. Hamilton, D.K. Spady, D.E. Polter.
Laser photocoagulation for the treatment of acute peptic ulcer bleeding.
N Engl J Med, 316 (1987), pp. 1618-1621
[79.]
C.P. Swain, J.S. Kirkham, P.R. Salmon, S.G. Brown, T.C. Northfield.
Controlled trial of Nd-YAG laser photocoagulation in bleeding peptic ulcers.
Lancet, 2 (1986), pp. 1113-1116
[80.]
C.P. Choudari, C. Rajgopal, R.A. Elton, K.R. Palmer.
Failures of endoscopic therapy for bleeding peptic ulcer: an analysis of risk factors.
Am J Gastroenterol, 89 (1994), pp. 1968-1972
[81.]
F.W. Green, M.M. Kaplan, L.E. Curtis, P.H. Levine.
Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage.
Gastroenterology, 74 (1978), pp. 38-43
[82.]
S.E. Patchett, H. Enright, N. Afdhal, W. O'Connell, D.P. O'Donoghue.
Clot lysis by gastric juice: an in vitro study.
Gut, 30 (1989), pp. 1704-1707
[83.]
A.N. Barkun, A.W. Cockeram, V. Plourde, R.N. Fedorak.
Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.
Aliment Pharmacol Ther, 13 (1999), pp. 1565-1584
[84.]
H.S. Merki, C.H. Wilder-Smith.
Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?.
Gastroenterology, 106 (1994), pp. 60-64
[85.]
D. Barer, A. Ogilvie, D. Henry, M. Drontield, D. Coggon, S. French, et al.
Cimetidine and tranexamic acid in the treatment of acute upper gastrointestinal bleeding.
N Engl J Med, 308 (1983), pp. 1571-1575
[86.]
R. Collins, M. Langman.
Treatment with histamine H2 antagonist in acute upper gastrointestinal bleeding: implications of randomized trials.
N Engl J Med, 313 (1985), pp. 660-666
[87.]
R.P. Walt, J. Cottrell, S.G. Mann, N.P. Freemantle.
Langman, MJ. Continuous intravenous famotidine for haemorrhage from peptic ulcer.
Lancet, 340 (1992), pp. 1058-1062
[88.]
R.P. Walt, J.R. Reynolds, M.J. Langman, H.L. Smart, G. Kitchingman, K.W. Somerville, et al.
Intravenous omeprazole rapidly raises intragastric pH.
Gut, 25 (1985), pp. 902-906
[89.]
J. Andersen, M. Strom, J. Naesdal, K. Leire, A. Walan.
Intravenous omeprazole: effect of a loading dose on 24-hour intragastric pH.
Aliment Pharmacol Ther, 4 (1990), pp. 65-72
[90.]
L.C. Baak, I. Biemond, J.B. Jansen, C.B. Lamers.
Repeated intravenous bolus injections of omeprazole: effects on 24-hour intragastric pH serum gastrin, and serum pepsinogen A and C.
Scand J Gastroenterol, 26 (1991), pp. 737-746
[91.]
J. Labenz, U. Peitz, C. Leusing, B. Tillenburg, A.L. Blum, G. Borsch.
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
Gut, 40 (1997), pp. 36-41
[92.]
G. Hasselgren, M. Keelan, P. Kirdeikis, L. Lee, K. Rohss, P. Sinclair, et al.
Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole.
Eur J Gastroenterol Hepatol, 10 (1998), pp. 601-606
[93.]
P. Netzer, C. Gaia, M. Sandoz, T. Huluk, A. Gut, F. Halter, et al.
Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Am J Gastroenterol, 94 (1999), pp. 351-357
[94.]
G. Brunner, P. Luna, M. Hartmann, W. Wurst.
Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.
Yale J Biol Med, 69 (1996), pp. 225-231
[95.]
T.K. Daneshmend, C.J. Hawkey, M.J.S. Langman, R.F. Logan, R.G. Long, R.P. Walt.
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.
BMJ, 304 (1992), pp. 143-147
[96.]
M.S. Khuroo, G.N. Yattoo, G. Javid, B.A. Khan, A.A. Shah, G.M. Gulzar, et al.
A comparison of omeprazole and placebo for bleeding peptic ulcer.
N Engl J Med, 336 (1997), pp. 1054-1058
[97.]
G. Hasselgren, T. Lind, L. Lundell, E. Aadland, P. Efskind, A. Falk, et al.
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.
Scand J Gastroenterol, 32 (1997), pp. 328-333
[98.]
C. Villanueva, J. Balanzó, X. Torras, S. Sáinz, G. Soriano, D. González, et al.
Omeprazole versus ranitidine as adjuvant therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
Endoscopy, 27 (1995), pp. 308-312
[99.]
O.B. Schaffalitzky de Muckadell, T. Havelund, H. Harling, S. Boesby, P. Snel, E.M. Vreeburg, et al.
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers.
Scand J Gastroenterol, 32 (1997), pp. 320-327
[100.]
H.J. Lin, W.C. Lo, F.Y. Lee, C.L. Perng, G.Y. Tseng.
A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
Arch Intern Med, 158 (1998), pp. 54-58
[101.]
J.Y. Lau, J.J. Sung, K.K. Lee, M.Y. Yung, S.K. Wong, J.C. Wu, et al.
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
N Engl J Med, 343 (2000), pp. 310-316
[102.]
G. Zuckerman, R. Welch, A. Douglas, R. Troxell, S. Cohen, S. Lorber, et al.
Controlled trial of medical therapy for active upper gastrointestinal bleeding and prevention of rebleeding.
Am J Med, 76 (1984), pp. 361-367
[103.]
T.F. Imperiale, S. Birgisson.
Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute non-variceal upper gastrointestinal hemorrhage: a metaanalysis.
Ann Intern Med, 127 (1997), pp. 1062-1071
[104.]
L. Kayasseh, K. Gyr, U. Keller, G.A. Stalder, M. Wall.
Somatostatin and cimetidine in peptic-ulcer hemorrhage.
Lancet, 1 (1980), pp. 844-846
[105.]
M. Basile, S. Celi, A. Parisi, N. Castiglione, S. Parisi.
Somatostatin in the treatment of severe gastrointestinal bleeding from peptic origin. A multicentric controlled trial.
Ital J Surg Sci, 14 (1984), pp. 31-35
[106.]
F. Coraggio, P. Scarpato, M. Spina, S. Lombardi.
Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract.
BMJ, 289 (1984), pp. 224
[107.]
A. Antonioli, M. Gandolfo, G.P. Rigo, G. Bianchi Porro, R. Cheli, F. Brancato, et al.
Somatostatin and cimetidine in the control of acute upper gastrointestinal bleeding. A controlled multicenter study.
Hepatogastroenterology, 33 (1986), pp. 71-74
[108.]
A.J. Torres, I. Landa, F. Hernández, J.M. Jover, A. Suárez, J. Arias, et al.
Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicentre controlled trial.
Br J Surg, 73 (1986), pp. 786-789
[109.]
F. Coraggio, G. Bertini, A. Catalano, P. Scarpato, L. Gualderi.
Clinical, controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract.
Digestion, 43 (1989), pp. 190-195
[110.]
Z. Tulassay, R. Gupta, J. Papp, A. Bodnar.
Somatostatin versus cimetidine in the treatment of actively bleeding duodenal ulcer: a prospective, randomized, controlled trial.
Am J Gastroenterol, 84 (1989), pp. 6-9
[111.]
I. Magnusson, T. Ihre, C. Johansson, U. Seligson, S. Törngren, K. Uvnas-Moberg.
Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage.
Gut, 26 (1985), pp. 221-226
[112.]
K.W. Somerville, D.A. Henry, J.G. Davies, K.R. Hine, C.J. Hawkey, M.J. Langman.
Somatostatin in treatment of haematemesis and melaena.
Lancet, 1 (1985), pp. 130-132
[113.]
N. Basso, M. Bagarani, F. Bracci, G. Cucchiara, D. Gizzonio, G. Grassini, et al.
Ranitidine and somatostatin. Their effects on bleeding from the upper gastrointestinal tract.
Arch Surg, 121 (1986), pp. 833-835
[114.]
E. Saperas, J.M. Piqué, R. Pérez-Ayuso, F. Fuster, J. Terés, J.M. Bordas, et al.
Somatostatin compared with cimetidine in the treatment of bleeding peptic ulcer without visible vessel.
Aliment Pharmacol Ther, 2 (1988), pp. 153-159
[115.]
J.Y.W. Lau, J.J.Y. Sung, Y.H. Lam, A.C.W. Chan, E.K.W. Ng, D.W.H. Lee, F.K.L. Chan, et al.
Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers.
N Engl J Med, 340 (1999), pp. 751-756
[116.]
S.P. Monig, T. Lubke, S.E. Baldus, H. Schafer, A.H. Holscher.
Early elective surgery for bleeding ulcer in the posterior duodenal bulb. Own results and review of the literature.
Hepatogastroenterology, 49 (2002), pp. 416-418
[117.]
A. Walan, J.P. Bader, M. Classen, CBHW Lamers, D.W. Piper, K. Rutgersson, et al.
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with bening gastric ulcer.
N Engl J Med, 320 (1989), pp. 69-75
[118.]
K.D. Bardhan, G. Bianchi Porro, K. Bose, M. Daly, R.F. Hinchliffe, E. Jonson, et al.
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers.
J Clin Gastroenterol, 8 (1986), pp. 408-413
[119.]
J.P. Bader, J.C. Delchier.
Clinical efficacy of pantoprazole compared with ranitidine.
Aliment Pharmacol Ther, 8 (1994), pp. 47-52
[120.]
E.J. Kuipers, J.C. Thijs.
Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease.
Aliment Pharmacol Ther, 9 (1995), pp. 59-69
[121.]
J.P. Gisbert, D. Boixeda, R. Aller, C. De la Serna, E. Sanz, C. Martín de Argila, et al.
Helicobacter pylori y hemorragia digestiva por úlcera duodenal: prevalencia de la infección, eficacia de tres terapias triples y papel de la erradicación en la prevención de la recidiva hemorrágica.
Med Clin (Barc), 112 (1999), pp. 161-165
[122.]
T.M. Ng, K.M. Fock, J.L. Khor, E.K. Teo, C.S. Sim, A.L. Tan, et al.
Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer.
Aliment Pharmacol Ther, 14 (2000), pp. 203-209
[123.]
A. García-Altés, A.J. Jovell, M. Serra-Prat, M. Aymerich.
Management of Helicobacter pylori in duodenal ulcer: a cost-effectiveness análisis.
Aliment Pharmacol Ther, 14 (2000), pp. 1631-1638
[124.]
A.M. Fendrick, M.E. Chernew, R.A. Hirth, B.S. Bloom.
Alternative management strategies for patients with suspected peptic ulcer disease.
Ann Intern Med, 123 (1995), pp. 260-268
[125.]
D.Y. Graham, K.S. Hepps, F.C. Ramírez, G.M. Lew, Z.A. Saeed.
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Scand J Gastroenterol, 28 (1993), pp. 939-942
[126.]
T. Rokkas, A. Karamaris, A. Mavrogeorgis, E. Rallis, N. Giannikos.
Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.
Gastrointest Endosc, 41 (1995), pp. 1-4
[127.]
G. Macri, S. Milani, E. Surrenti, M.T. Passaleva, G. Salvadori, C. Surrenti.
Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.
Am J Gastroenterol, 3 (1998), pp. 925-927
[128.]
J.J.Y. Sung, W.K. Leung, R. Suen, V.K.S. Leung, F.K.L. Chan, T.K.W. Ling, J.Y.W. Lau, et al.
One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
Dig Dis Sci, 42 (1997), pp. 2524-2528
[129.]
R. Pellicano, S. Pierre, N. Leone, A. Repici, C. De Angelis, R. Rizzi.
The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer.
J Clin Gastroenterol, 32 (2001), pp. 222-224
[130.]
J.P. Gisbert, L. González, X. Calvet, N. García, T. López, M. Roqué, et al.
Proton pump inhibitor, clarithromycin and amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.
Aliment Pharmacol Ther, 14 (2000), pp. 1319-1328
[131.]
X. Calvet, E. Gené, T. López, J.P. Gisbert.
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori?.
A cost-effectiveness analysis. Aliment Pharmacol Ther, 15 (2001), pp. 1067-1076
[132.]
M. Vallvé, M. Vergara, J.P. Gisbert, X. Calvet.
Single versus double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Aliment Pharmacol Ther, 16 (2002), pp. 1149-1156
[133.]
Graham DY, Osato MS, Hoffman J, Opekun AR, Anderson SY, Kwon DH, et al. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study
[134.]
X. Calvet, N. García, E. Gené, R. Campo, E. Brullet, I. Sanfeliu.
Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.
Aliment Pharmacol Ther, 15 (2001), pp. 1061-1065
[135.]
X. Calvet, J. Ducons, J. Guardiola, L. Titó, V. Andreu, F. Bory.
Guirao R (Gresca). One-week triple versus quadruple therapy for Helicobacter pylori infection: a randomized trial.
Aliment Pharmacol Ther, 16 (2002), pp. 1261-1267
[136.]
R.J. Hopkins, L.S. Girardi, E.A. Turney.
Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.
Gastroenterology, 110 (1996), pp. 1244-1252
[137.]
F. Lerang, B. Moum, P. Mowinckel, J.B. Hang, E. Ragnhildstveit, T. Berge, et al.
Accuracy of seven different test for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonist on test results.
Scand J Gastroenterol, 33 (1998), pp. 364-369
[138.]
W.D. Chey, M. Spybrook, S. Carpenter, T.T. Nostrant, G.H. Elta, J.M. Scheiman.
Prolonged effect of omeprazole on the 14C-urea breath test.
Am J Gastroenterol, 91 (1996), pp. 89-92
[139.]
W.D. Chey, M. Woods, J.M. Scheiman, T.T. Nostrant, J. Del Valle.
Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependant mechanism.
Am J Gastroenterol, 92 (1997), pp. 446-450
[140.]
N.D. Yeomans, Z. Tulassay, L. Juhasz, I. Racz, J.M. Howard, C.J. Van Rensburg.
et al (ASTRONAUT). A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs.
N Engl J Med, 338 (1998), pp. 719-726
[141.]
C.J. Hawkey, J.A. Karrasch, L. Szczepanski, D.G. Walker, A. Barkun, A.J. Swannell.
et al (OMNIUM). Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs.
N Engl J Med, 338 (1998), pp. 727-734
[142.]
W.K. Leung, J.J.Y. Sung, K.L.K. Siu, F.K. Chan, T.K. Ling, A.F. Cheng.
False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood.
Am J Gastroenterol, 93 (1998), pp. 1914-1918
[143.]
J.M. Lee, N.P. Breslin, C. Fallon, C.A. O'Morain.
Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding.
Am J Gastroenterol, 95 (2000), pp. 70
[144.]
F.K. Chan, S.C. Chung, B.Y. Suen, Y.T. Lee, W.K. Leung, V.K. Leung, et al.
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
N Engl J Med, 344 (2001), pp. 967-973
[145.]
F.K.L. Chan, K.F. To, J.C.Y. Wu, M.Y. Yung, W.K. Leung, T. Kwok, et al.
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
Lancet, 359 (2002), pp. 9-13
[146.]
J.P. Gisbert, X. Calvet, F. Gomollón, R. Sáinz.
Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la Conferencia Española de Consenso.
Med Clin (Barc), 114 (2000), pp. 185-195
[147.]
C. Bombardier, L. Laine, A. Reicin, D. Shapiro, R. Burgos-Vargas, B. Davis, et al.
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.
N Engl J Med, 343 (2000), pp. 1520-1528
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
